Related Experiment Video
Updated: Jan 25, 2026

In Vivo Proximity Biotinylation for Protein Interaction Studies in Paramecium tetraurelia
Published on: September 12, 2025
Proximity biotinylation identifies a set of conformation-specific interactions between Merlin and cell junction
Robert F Hennigan1, Jonathan S Fletcher2, Steven Guard3
1Division of Experimental Hematology and Cancer Biology, Cincinnati Children's Hospital, Cincinnati, OH 45229, USA. robert.hennigan@cchmc.org.
Abstract:
Neurofibromatosis type 2 is an inherited, neoplastic disease associated with schwannomas, meningiomas, and ependymomas and that is caused by inactivation of the tumor suppressor gene NF2 The NF2 gene product, Merlin, has no intrinsic catalytic activity; its tumor suppressor function is mediated through the proteins with which it interacts. We used proximity biotinylation followed by mass spectrometry and direct binding assays to identify proteins that associated with wild-type and various mutant forms of Merlin in immortalized Schwann cells. We defined a set of 52 proteins in close proximity to wild-type Merlin. Most of the Merlin-proximal proteins were components of cell junctional signaling complexes, suggesting that additional potential interaction partners may exist in adherens junctions, tight junctions, and focal adhesions. With mutant forms of Merlin that cannot bind to phosphatidylinositol 4,5-bisphosphate (PIP2) or that constitutively adopt a closed conformation, we confirmed a critical role for PIP2 binding in Merlin function and identified a large cohort of proteins that specifically interacted with Merlin in the closed conformation. Among these proteins, we identified a previously unreported Merlin-binding protein, apoptosis-stimulated p53 protein 2 (ASPP2, also called Tp53bp2), that bound to closed-conformation Merlin predominately through the FERM domain. Our results demonstrate that Merlin is a component of cell junctional mechanosensing complexes and defines a specific set of proteins through which it acts.
Insights
Neurofibromatosis type 2 involves tumor suppressor gene NF2 inactivation. Researchers identified 52 Merlin-associated proteins, revealing Merlin’s role in cell junction mechanosensing and discovering a new binding partner, ASPP2.
Area of Science:
- Cell Biology
- Genetics
- Oncology
Background:
- Neurofibromatosis type 2 (NF2) is an inherited neoplastic disorder.
- It is caused by mutations in the NF2 tumor suppressor gene, leading to the inactivation of its protein product, Merlin.
- Merlin's tumor suppressor function is mediated by its interactions with other proteins.
Purpose of the Study:
- To identify proteins that interact with Merlin, the NF2 gene product.
- To understand Merlin's role in cell junction signaling and mechanosensing.
- To investigate the impact of Merlin mutations on protein interactions.
Main Methods:
- Proximity biotinylation followed by mass spectrometry in immortalized Schwann cells.
- Direct binding assays to confirm protein interactions.
- Analysis of wild-type and mutant Merlin forms, including PIP2-binding and constitutively closed mutants.
Main Results:
- Identified 52 proteins in close proximity to wild-type Merlin, many involved in cell junction signaling.
- Confirmed the critical role of PIP2 binding in Merlin function.
- Discovered a novel Merlin-binding protein, ASPP2 (Tp53bp2), interacting with closed-conformation Merlin.
Conclusions:
- Merlin functions as a component of cell junctional mechanosensing complexes.
- Merlin interacts with a specific set of proteins to exert its tumor suppressor function.
- The findings provide new insights into the molecular mechanisms underlying NF2.
Related Concept Videos
Conformity
Overview of Cell-Cell Junctions
Occluding or Tight...
Intrinsically Disordered Proteins
Cell Specific Gene Expression
Conformations of Butane
P-N junction

